Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Feb 15, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: Citi's 2024 Unplugged...
-
Feb 12, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series — which will...
-
Feb 1, 2024
Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024 Q1 revenue of $4.7 billion increased 2.6% as reported, 1.6% currency-neutral and 2.4% organic Q1 GAAP and...
-
Jan 30, 2024
AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions FRANKLIN LAKES, N.J. and OREM, Utah, Jan. 30, 2024...
-
Jan 25, 2024
Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates NAIROBI, Kenya, Jan. 25, 2024 /PRNewswire/ -- BD (Becton,...
-
Jan 23, 2024
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common...
-
Jan 23, 2024
Companies to automate a critical step of high-throughput single-cell multiomics experiments FRANKLIN LAKES, N.J., Jan. 23, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a...
-
Jan 10, 2024
Survey Conducted in the US, UK and Sweden Exposes Lack of Education on Options and Unclear Guidance on HPV Testing FRANKLIN LAKES, N.J., Jan. 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and...
-
Jan 5, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday,...
-
Jan 4, 2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its first quarter of fiscal year 2024 on...
-
Dec 22, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday,...
-
Dec 20, 2023
Company Reinforces its Commitment to Achieving Net-Zero Emissions and Supporting Decarbonization Across Operations by Joining Health Sector Climate Pledge FRANKLIN LAKES, N.J. (Dec. 20, 2023) –...
-
Dec 11, 2023
Company Reinforces its Longstanding Commitment to Help Improve Health Equity and Expand Access to Care Among Vulnerable Populations FRANKLIN LAKES, N.J., Dec. 11, 2023 /PRNewswire/ -- BD (Becton,...
-
Dec 7, 2023
BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations FRANKLIN LAKES, N.J., Dec. 7, 2023...
-
Dec 5, 2023Company’s Time-Honored Service Trips Enable Associate Volunteers to Provide Hands-On Skills Training for Health Care Workers and Support Health Infrastructure
FRANKLIN LAKES, N.J. (Dec. 5, 2023) – Today, in recognition of International Volunteer Day 2023, leading global medical technology company, BD (Becton, Dickinson and Company) (NYSE: BDX),...
-
Dec 4, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series, which will...
-
Nov 30, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA) Safety...
-
Nov 30, 2023
SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success FRANKLIN LAKES, N.J., Nov. 30, 2023 /PRNewswire/ -- BD...
-
Nov 21, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman, MD, FACS, has been named executive vice president and...
-
Nov 20, 2023
WASHINGTON, D.C., USA, Nov. 20, 2023 – BD (Becton Dickinson and Company), a leading global medical technology company, and Bio Farma, a state-owned life science company in Indonesia, signed a...
-
Nov 14, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday,...
-
Nov 9, 2023
Execution of BD 2025 Strategy Driving Durable, Broad-Based Growth Q4 revenue of $5.1 billion increased 6.8% as reported and 5.9% on a currency-neutral basis Q4 revenue from base business (which...
-
Nov 9, 2023
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.95 per common share, an increase of 4.4% from the previous quarter. The dividend...
-
Nov 2, 2023
New Peripheral Line Draw Solution Delivers First and Only Compatibility with Integrated Catheters, Bringing Elevated Standard of Care to More U.S. Hospitals FRANKLIN LAKES, N.J., Nov. 2, 2023...
-
Nov 1, 2023
Results of the SAFE-DCB Registry support long-term safety and effectiveness for the Lutonix™ DCB in a real-world patient population with femoropopliteal disease.